1. Immunological evaluation of peptide vaccination for cancer patients with the HLA ‐A26 allele
    Shinjiro Sakamoto et al, 2015, Cancer Science CrossRef
  2. Phase I clinical study of personalized peptide vaccination combined with radiotherapy for advanced hepatocellular carcinoma
    Jie Shen et al, 2017, World Journal of Gastroenterology CrossRef
  3. Single nucleotide polymorphisms of the haptoglobin gene in non-small cell lung cancer treated with personalized peptide vaccination
    Kayoko Waki et al, 2017, Oncology Letters CrossRef
  4. Prospects for a personalized peptide vaccine against lung cancer
    Yoshiro Nakahara et al, 2019, Expert Review of Vaccines CrossRef
  5. Integrity of circulating cell-free DNA as a prognostic biomarker for vaccine therapy in patients with nonsmall cell lung cancer
    Kayoko Waki et al, 2021, Immunopharmacology and Immunotoxicology CrossRef
  6. Feasibility Study of Personalized Peptide Vaccination for Advanced Small Cell Lung Cancer
    Shinjiro Sakamoto et al, 2017, Clinical Lung Cancer CrossRef
  7. Early phase II study of mixed 19‐peptide vaccine monotherapy for refractory triple‐negative breast cancer
    Uhi Toh et al, 2020, Cancer Science CrossRef
  8. Prospect and progress of personalized peptide vaccinations for advanced cancers
    Shinjiro Sakamoto et al, 2016, Expert Opinion on Biological Therapy CrossRef
  9. Phase I study of a new cancer vaccine of ten mixed peptides for advanced cancer patients
    Satoru Iwasa et al, 2016, Cancer Science CrossRef